576 Blocking FGFR2 and SHP2 can effectively suppress tumor progression in gastric cancers with FGFR2 alteration
Yue Wang,
Baorui Liu,
Yue Zhang,
Jia Wei,
Hanbing Wang,
Lixia Yu
Affiliations
Yue Wang
2Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China
Baorui Liu
The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China
Yue Zhang
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
Jia Wei
3The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing, Jiangsu, China
Hanbing Wang
1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China
Lixia Yu
1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China